Cargando…
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
BACKGROUND: Although it has long been appreciated that ovarian carcinoma subtypes (serous, clear cell, endometrioid, and mucinous) are associated with different natural histories, most ovarian carcinoma biomarker studies and current treatment protocols for women with this disease are not subtype spe...
Autores principales: | Köbel, Martin, Kalloger, Steve E, Boyd, Niki, McKinney, Steven, Mehl, Erika, Palmer, Chana, Leung, Samuel, Bowen, Nathan J, Ionescu, Diana N, Rajput, Ashish, Prentice, Leah M, Miller, Dianne, Santos, Jennifer, Swenerton, Kenneth, Gilks, C. Blake, Huntsman, David |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592352/ https://www.ncbi.nlm.nih.gov/pubmed/19053170 http://dx.doi.org/10.1371/journal.pmed.0050232 |
Ejemplares similares
-
Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma
por: Prentice, Leah M, et al.
Publicado: (2007) -
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
por: McAlpine, Jessica N, et al.
Publicado: (2009) -
Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
por: Press, Joshua Z, et al.
Publicado: (2008) -
Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases
por: Rajput, Ashish B., et al.
Publicado: (2007) -
Claudin 4 Is Differentially Expressed between Ovarian Cancer Subtypes and Plays a Role in Spheroid Formation
por: Boylan, Kristin L. M., et al.
Publicado: (2011)